Eastman Chemical Company Profile Avatar - Palmy Investing

Eastman Chemical Company

Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based b…
Chemicals - Specialty
US, Kingsport [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -14.63 40.19 47.07
Graham Fair Price -26.14 38.62 52.29
PEG 238.98 -0.38 0.11
Price/Book 9.50 2.13 1.94
Price/Cash Flow 49.60 -58.29 38.97
Prices/Earnings 108.73 17.84 8.55
Price/Sales 6.14 5.10 4.81
Price/FCF 49.60 -58.29 38.97
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 12.77 0.23 0.20
Operating Margin 33.09 0.12 0.09
ROA -47.19 0.01 0.02
ROE 0.06 0.03 -47.54
ROIC 0.01 0.02 42.44
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.02 -0.05 -52.82
Dividends QOQ < 0.005 0.02 272.96
EBIT QOQ -0.24 0.39 64.70
EPS QOQ 0.75 -0.46 -38.42
FCF QOQ -0.02 -1.74 -7974.26
Revenue QOQ -0.46 0.05 -89.75
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 86.26 89.54 3.81
Days Sales Outstanding (DSO) 47.10 49.68 5.47
Inventory Turnover 1.04 1.01 -3.67
Debt/Capitalization 0.47 0.48 1.73
Quick Ratio 0.66 0.68 3.02
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 46.25 47.17 1.98
Cash 4.65 4.34 -6.81
Capex -1.53 -1.58 -3.86
Free Cash Flow 2.31 -1.72 -25.36
Revenue 18.69 19.66 5.21
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.35 1.39 2.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 13.85 11.26 -18.73
Naive Interpretation Member
06 - Financial Health · Weak
End of EMN's Analysis
CIK: 915389 CUSIP: 277432100 ISIN: US2774321002 LEI: - UEI: -
Secondary Listings
EMN has no secondary listings inside our databases.